Clinical Trials for Ix Therapeutics

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 5% Total Body Surface Area Burns

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis

Relative Bioavailability of NX-5948 Tablets Vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets

Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection

Study of REM-422 in Patients With AML or Higher Risk MDS

Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

ADH1 and ADH2 Disease Monitoring Study (DMS)

A Study of NX-1607 in Adults With Advanced Malignancies

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies